Effects of Spirulina Supplementation on Mental Health in Healthy Adults
Launched by ARIZONA STATE UNIVERSITY · Apr 12, 2025
Trial Information
Current as of September 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of spirulina, a type of blue-green algae known for its health benefits, on mood and mental sharpness in healthy adults. Participants will take a daily supplement of 3 grams of spirulina for 8 weeks to see if it can help improve their mental health compared to those who receive a placebo (a pill that looks like the supplement but has no active ingredients).
To be eligible for the study, you should be a healthy adult between the ages of 18 and 65, without any serious health issues or mental health diagnoses like depression. You should also not be taking any medications for mental health or other conditions, and you should not be pregnant or breastfeeding. Participants will be recruited from a university campus, and the trial is not yet recruiting, so there is still time to learn more before deciding to participate. Overall, this study aims to explore how a natural supplement like spirulina might help boost mood and cognitive function in everyday individuals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy adults
- • ages 18-65
- • no underlying chronic disease or acute conditions
- • no autoimmune conditions
- • do not consume alcohol in excess, smoke, use recreational drugs
- • does not follow restrictive diets
- • will be recruited from the ASU university campus.
- Exclusion Criteria:
- • not have been clinically diagnosed with depression
- • not taking antidepressants, anxiety, or stress medications, or any other medications
- • drugs, or supplements that could influence mental capacities
- • not pregnant or breastfeeding
- • not a competitive athlete
About Arizona State University
Arizona State University (ASU) is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, ASU leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical research practices and collaboration with healthcare professionals, ASU strives to translate research findings into practical applications that benefit society. The university's focus on community engagement and real-world impact underscores its role as a pivotal player in the advancement of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Phoenix, Arizona, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported